Maravai LifeSciences Holdings, Inc.

$4.43+4.98%(+$0.21)
TickerSpark Score
65/100
Solid
60
Valuation
30
Profitability
45
Growth
88
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRVI research report →

52-Week Range81% of range
Low $1.99
Current $4.43
High $5.00

Companywww.maravai.com

Maravai LifeSciences Holdings, Inc. , a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.

CEO
Bernd Brust
IPO
2020
Employees
570
HQ
San Diego, CA, US

Price Chart

+84.58% · this period
$4.85$3.43$2.01May 20Nov 18May 20

Valuation

Market Cap
$1.22B
P/E
-6.20
P/S
11.38
P/B
3.07
EV/EBITDA
-21.85
Div Yield
0.00%

Profitability

Gross Margin
29.00%
Op Margin
21.93%
Net Margin
-51.07%
ROE
-44.72%
ROIC
6.48%

Growth & Income

Revenue
$185.74M · -28.34%
Net Income
$-130,773,000 · 9.72%
EPS
$-0.91 · 13.33%
Op Income
$-6,738,000
FCF YoY
-218.67%

Performance & Tape

52W High
$5.00
52W Low
$1.99
50D MA
$3.48
200D MA
$3.25
Beta
0.62
Avg Volume
2.07M

Get TickerSpark's AI analysis on MRVI

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 16, 26Dolan Christineother28,661
Mar 16, 26ORESHACK KURTother39,976
Jan 15, 26Dolan Christineother28,934
Jan 15, 26ORESHACK KURTother31,902
Dec 8, 25LUCIER GREGORY Tbuy48,528
Dec 5, 25LUCIER GREGORY Tbuy51,472
Nov 14, 25Dolan Christineother4,300
Nov 13, 25Brust Berndbuy216,212
Nov 12, 25Brust Berndbuy93,358
Nov 11, 25Brust Berndbuy157,201

Our MRVI Coverage

We haven't published any research on MRVI yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MRVI Report →

Similar Companies